Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Comment by DanielBoone733on Feb 21, 2017 9:38pm
139 Views
Post# 25875090

RE:RE:Medical > Recreational

RE:RE:Medical > Recreational

Shout out to BearlyBullish as that post was well put. All very good points.

Just to clarify with financials Friday morning that will be for the fiscal year 2016 up to Oct. 31st from what I understand.  

The better financials for Q1 2017 will come mid March and those should contain CMED's "record breaking" months December and January. Those should be impressive, and then future finacials will be exponentially better based on CMED's patient growth.

Estimates from the AltaCorp document I have suggest that FY 2016 results should show 10.1 million in sales and negative 2 million EBITDA. 
Q1 of 2017 will already be estimated at 4.32 million alone and that document came out before the record growth in January!

Sales in 2017 of 24 million (up 146%)
Sales in 2018 55 million (up another 122%)
Sales in 2019 110 (up another 100%!!!) 

How do you like them apples??


<< Previous
Bullboard Posts
Next >>